The partnership will allow clinical laboratories to integrate multiple Panther Systems into automated workflows designed to increase testing capacity and improve sample tracking.
A 2025 Westgard QC survey finds daily out-of-control quality control events reported by 33% of labs worldwide and 45% in the US, raising concerns about current QC practices amid rising operational pressures.
Clinical labs are adopting broader cancer diagnostics—including whole-genome sequencing and multi-omic testing—to deliver more comprehensive molecular insights and improve disease monitoring.
Diazyme Laboratories has acquired Carolina Liquid Chemistries, integrating CLC’s chemistry systems and reagents with Diazyme’s diagnostic technologies to expand solutions for reference and clinical laboratories.
Bio-Rad has launched Vericheck ddPCR kits for quality control in cell and gene therapy manufacturing, offering validated workflows for mycoplasma detection, capsid analysis, and residual DNA quantification.
The company showcased its latest automation and informatics platforms designed to improve laboratory efficiency and diagnostic accuracy.
Using microfluidic shear stress, the system detaches living cells from excised tissue to support pathology workflows and downstream diagnostic testing.
Century Health and GI Partners of Illinois have partnered to create a real-world data ecosystem for IBD and MASH, leveraging AI to extract clinical insights from lab data, pathology reports, and imaging to support research and pharmaceutical innovation.
Emerging hazards like aerosolized chemicals and laser equipment demand upgraded protection.
Caresfield launched the Resilience-Ready Lab initiative at ADLM 2026, introducing products aimed at improving specimen integrity and supply chain resilience to help labs meet 2026 National Performance Goals.